(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202503 | 202403 | % Var | 202503 | 202403 | % Var | 202503 | 202403 | % Var | |
| Sales | 0.96 | 0.75 | 28.00 | 6.11 | 5.55 | 10.09 | 6.11 | 5.55 | 10.09 |
| Other Income | 6.08 | 4.84 | 25.62 | 20.09 | 19.92 | 0.85 | 20.09 | 19.92 | 0.85 |
| PBIDT | 2.85 | 0.91 | 213.19 | 10.58 | 9.10 | 16.26 | 10.58 | 9.10 | 16.26 |
| Interest | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| PBDT | 2.84 | 0.91 | 212.09 | 10.57 | 9.10 | 16.15 | 10.57 | 9.10 | 16.15 |
| Depreciation | 0.24 | 0.24 | 0.00 | 0.98 | 0.98 | 0.00 | 0.98 | 0.98 | 0.00 |
| PBT | 2.60 | 0.67 | 288.06 | 9.59 | 8.12 | 18.10 | 9.59 | 8.12 | 18.10 |
| TAX | 3.27 | -2.03 | -261.08 | 6.42 | 1.62 | 296.30 | 6.42 | 1.62 | 296.30 |
| Deferred Tax | -0.08 | 0.00 | 0.00 | 2.02 | 1.49 | 35.57 | 2.02 | 1.49 | 35.57 |
| PAT | -0.67 | 2.70 | -124.81 | 3.17 | 6.50 | -51.23 | 3.17 | 6.50 | -51.23 |
| Equity | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 | 49.96 | 49.96 | 0.00 |
| PBIDTM(%) | 296.88 | 121.33 | 144.68 | 173.16 | 163.96 | 5.61 | 173.16 | 163.96 | 5.61 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1696.65 |
| Dr. Reddys Lab | 1218.30 |
| Cipla | 1226.65 |
| Zydus Lifesciences | 936.00 |
| Lupin | 2339.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: